Anavex Life Sciences Corp. (AVXL)
1.82
-0.07
(-3.70%)
USD |
NASDAQ |
Oct 02, 16:00
1.815
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences EPS Diluted (Quarterly) : 0.0842 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0842 |
| March 31, 2026 | -0.0576 |
| December 31, 2025 | -0.0638 |
| September 30, 2025 | -0.1144 |
| June 30, 2025 | -0.1551 |
| March 31, 2025 | -0.1316 |
| December 31, 2024 | -0.1428 |
| September 30, 2024 | -0.137 |
| June 30, 2024 | -0.1445 |
| March 31, 2024 | -0.1279 |
| December 31, 2023 | -0.105 |
| September 30, 2023 | -0.1238 |
| June 30, 2023 | -0.1395 |
| March 31, 2023 | -0.1674 |
| December 31, 2022 | -0.1664 |
| September 30, 2022 | -0.1845 |
| June 30, 2022 | -0.1597 |
| March 31, 2022 | -0.1369 |
| December 31, 2021 | -0.1432 |
| September 30, 2021 | -0.1543 |
| June 30, 2021 | -0.1442 |
| March 31, 2021 | -0.1189 |
| December 31, 2020 | -0.1222 |
| September 30, 2020 | -0.0977 |
| June 30, 2020 | -0.1098 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.124 |
| December 31, 2019 | -0.1204 |
| September 30, 2019 | -0.0737 |
| June 30, 2019 | -0.1314 |
| March 31, 2019 | -0.1538 |
| December 31, 2018 | -0.1494 |
| September 30, 2018 | -0.1261 |
| June 30, 2018 | -0.06 |
| March 31, 2018 | -0.11 |
| December 31, 2017 | -0.09 |
| September 30, 2017 | -0.12 |
| June 30, 2017 | -0.09 |
| March 31, 2017 | -0.04 |
| December 31, 2016 | -0.08 |
| September 30, 2016 | -0.18 |
| June 30, 2016 | -0.06 |
| March 31, 2016 | -0.06 |
| December 31, 2015 | -0.12 |
| September 30, 2015 | -0.1672 |
| June 30, 2015 | -0.24 |
| March 31, 2015 | -0.12 |
| December 31, 2014 | -0.08 |
| September 30, 2014 | -0.96 |
| June 30, 2014 | -0.12 |
| March 31, 2014 | -0.12 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.824M |
| Total Expenses (Quarterly) | -7.824M |
| Enterprise Value | 50.38M |
| Earnings Yield | -8.33% |
| Normalized Earnings Yield | -8.330 |